Multiply Labs Raises $75M in Series B Funding to Scale Robotic Drug Manufacturing
This story is from 2026-09-17. It is preserved in the archive; the latest stories are on the live feed.
Insider Brief Multiply Labs has raised $75 million in Series B funding to expand its robotic manufacturing platform for cell and gene therapies and other advanced biologics. The round brings the San Francisco company’s total funding to more than $100 million since its founding in 2016. AstraZeneca…
Read the full story at AI Insider ↗
Timeline · 1 report
- 2026-09-17 00:56 · AI Insider
Multiply Labs Raises $75M in Series B Funding to Scale Robotic Drug Manufacturing